Elixir has engaged in a strategic cooperation with Glatt Pharmaceutical Services. In this framework; Elixir performs laboratory scale, early stage development studies for some specific projects, while Glatt Pharmaceutical Services conducts pilot/commercial scale, late stage development tasks at its US and EU GMP approved facilities located in Binzen, Germany.

Thanks to this cooperation, pharmaceutical companies that work with Elixir will have the opportunity to submit their applications to FDA and European authorities.